McKinley Carter Wealth Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,658
| Closed | -$4.49M | – | 310 |
|
|
2025
Q1 | $4.49M | Buy |
64,658
+234
| +0.4% | +$16.2K | 0.28% | 70 |
|
|
2024
Q4 | $5.54M | Buy |
64,424
+1,797
| +3% | +$155K | 0.34% | 65 |
|
|
2024
Q3 | $7.46M | Sell |
62,627
-932
| -1% | -$111K | 0.45% | 49 |
|
|
2024
Q2 | $9.07M | Buy |
63,559
+1,060
| +2% | +$151K | 0.58% | 43 |
|
|
2024
Q1 | $8.02M | Buy |
62,499
+2,143
| +4% | +$275K | 0.54% | 45 |
|
|
2023
Q4 | $6.24M | Buy |
60,356
+16,293
| +37% | +$1.69M | 0.46% | 55 |
|
|
2023
Q3 | $4.01M | Buy |
44,063
+3,527
| +9% | +$321K | 0.32% | 62 |
|
|
2023
Q2 | $3.28M | Buy |
+40,536
| New | +$3.28M | 0.25% | 74 |
|
|
2018
Q2 | – | Sell |
-480
| Closed | -$12K | – | 307 |
|
|
2018
Q1 | $12K | Buy |
+480
| New | +$12K | ﹤0.01% | 368 |
|
|
2014
Q2 | – | Sell |
-11,100
| Closed | -$253K | – | 98 |
|
|
2014
Q1 | $253K | Hold |
11,100
| – | – | 0.28% | 78 |
|
|
2013
Q4 | $205K | Buy |
+11,100
| New | +$205K | 0.2% | 111 |
|